Skip to content
lifestyle.dietfitnessforall.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
ELI LILLY AND COMPANY
USOPC Announces the Team USA Athlete Recovery Program in Partnership with Eli Lilly and Company
March 9, 2026
Lilly’s Retevmo (selpercatinib) delivers substantial event-free survival benefit as an adjuvant therapy in early-stage RET fusion-positive lung cancer
March 9, 2026
Lilly to acquire Orna Therapeutics to advance cell therapies
March 8, 2026
Lilly Employer Connect platform launches with over fifteen independent program administrators offering tailored obesity coverage options to expand access to patients
March 5, 2026
Zepbound (tirzepatide), the most prescribed weight management medication in 2025, now available in multi-dose KwikPen
February 23, 2026
Lilly’s Taltz (ixekizumab) and Zepbound (tirzepatide) used together delivered superior efficacy in first-of-its-kind Phase 3b trial for adults with psoriasis and obesity or overweight
February 20, 2026
Lilly reports fourth-quarter 2025 financial results and provides 2026 guidance
February 4, 2026
←
Previous Page
1
2
3
4